ArticleBMC medicine2026

Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study.

Jinglei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.